Excessive activated T-cell proliferation after anti-CD19 CAR T-cell therapy

Global Manufacturing of CAR T Cell Therapy

(2017) Bruce L. Levine et al.   Molecular Therapy-Methods & Clinical Development

CAR-T Cell Therapy for Lymphoma

(2016) Carlos A. Ramos et al.   Annual Review of Medicine

Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition

(2016) Leonid Cherkassky et al.   JOURNAL OF CLINICAL INVESTIGATION

Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia

(2016) Bo Cai et al.   Journal of Hematology & Oncology

At The Bedside: Clinical review of chimeric antigen receptor (CAR) T cell therapy for B cell malignancies

(2016) Olalekan O. Oluwole et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Chimeric Antigen Receptor T cells for B Cell Neoplasms: Choose the Right CAR for You

(2016) Marco Ruella et al.   Current Hematologic Malignancy Reports

Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia

(2015) Hanren Dai et al.   OncoImmunology

Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies

(2014) Shannon L. Maude et al.   CANCER JOURNAL

Effective response and delayed toxicities of refractory advanced diffuse large B-cell lymphoma treated by CD20-directed chimeric antigen receptor-modified T cells

(2014) Yao Wang et al.   CLINICAL IMMUNOLOGY

Cellular immunotherapy for patients with reactivation of JC and BK polyomaviruses after transplantation

(2014) Jiju Mani et al.   CYTOTHERAPY

Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

(2014) M. L. Davila et al.   Science Translational Medicine